-
141
Differences in expression profiles in malingant melanoma patients according to immunotherapy response
Published 2018-01-01Subjects: Get full text
Article -
142
Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy
Published 2024-12-01Subjects: Get full text
Article -
143
An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
Published 2025-02-01Subjects: Get full text
Article -
144
Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy
Published 2024-12-01“…They are also increasingly being implemented in cancer immunotherapy because of their ability to deliver drugs and modulate the immune system. …”
Get full text
Article -
145
Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer
Published 2014-01-01“…In the future, such strategies will be combined with negative regulatory signal blockade and enhanced recognition to comprehensively enhance NK cells for immunotherapy.…”
Get full text
Article -
146
The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review
Published 2025-01-01“…As cancer immunotherapy evolves, the integration of TCM into conventional treatment regimens may offer enhanced therapeutic efficacy, reduced side effects, and improved overall outcomes for cancer patients. …”
Get full text
Article -
147
Harnessing dendritic cells for pancreatic cancer immunotherapy: a novel promising approach
Published 2025-01-01Get full text
Article -
148
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
Published 2025-01-01“…However, it also potentiates immunotherapy by supporting immune cell trafficking. …”
Get full text
Article -
149
Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer
Published 2025-01-01Subjects: Get full text
Article -
150
Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
151
Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer
Published 2025-01-01Subjects: Get full text
Article -
152
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Published 2021-01-01“…Cancer immunotherapy, which reactivates weakened immune cells of cancer patients, has yielded great success in recent years. …”
Get full text
Article -
153
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
Published 2019-01-01“…Lung cancer is one of the deadliest and most common malignancies in the world, representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly changing standard treatment schedule and outcomes for patients with advanced malignancies. …”
Get full text
Article -
154
Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
155
Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
Published 2025-02-01Subjects: “…ICI Immunotherapy…”
Get full text
Article -
156
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Published 2025-01-01Subjects: “…combination immunotherapy…”
Get full text
Article -
157
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
158
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
Published 2014-01-01“…Immunotherapy emerged as a promising therapeutic approach to highly incurable malignant gliomas due to tumor-specific cytotoxicity, minimal side effect, and a durable antitumor effect by memory T cells. …”
Get full text
Article -
159
Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
Published 2025-01-01Subjects: Get full text
Article -
160
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
Published 2025-02-01Subjects: Get full text
Article